Research graph
References from Plasma heart-type fatty acid-binding protein, omega-3 fatty acids and adverse cardiac events in the general population. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.jacc.2020.11.010
10.1016/j.jacc.2020.11.010 · External reference
10.1016/0735-1097(96)87731-x
10.1016/0735-1097(96)87731-x · External reference
10.1016/j.resuscitation.2008.06.009
10.1016/j.resuscitation.2008.06.009 · External reference
10.1515/cclm.2000.034
10.1515/cclm.2000.034 · External reference
10.1093/qjmed/hch037
10.1093/qjmed/hch037 · External reference
10.1373/clinchem.2005.056143
10.1373/clinchem.2005.056143 · External reference
Heart-type fatty acid-binding protein: an overlooked cardiac biomarker
10.1080/07853890.2020.1800075 · 2020 · External reference
Association of H-FABP with cardiovascular events: A systematic review
10.34172/jcvtr.33039 · 2024 · External reference
Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials
10.1016/j.mayocp.2020.08.034 · 2021 · External reference
10.1161/circulationaha.119.044440
10.1161/circulationaha.119.044440 · External reference
10.1056/nejmoa1812792
10.1056/nejmoa1812792 · External reference
UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age
10.1371/journal.pmed.1001779 · 2015 · External reference
10.1038/s41586023-06592-6
10.1038/s41586023-06592-6 · External reference
An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health
10.3390/nu13010204 · 2021 · External reference
Heart-type fatty acid binding protein predicts cardiovascular events in patients with stable coronary artery disease: a prospective cohort study
10.21037/atm-20-2493 · 2020 · External reference
Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort Study
10.1053/j.ajkd.2022.01.424 · 2022 · External reference
10.1161/01.cir.96.2.509
10.1161/01.cir.96.2.509 · External reference
10.1016/j.jacc.2012.12.026
10.1016/j.jacc.2012.12.026 · External reference
10.1161/circheartfailure.112.000075
10.1161/circheartfailure.112.000075 · External reference
10.1038/nrcardio.2012.37
10.1038/nrcardio.2012.37 · External reference
10.1001/jama.2010.1768
10.1001/jama.2010.1768 · External reference
10.1001/jama.2010.1708
10.1001/jama.2010.1708 · External reference
10.1016/j.jacc.2012.12.048
10.1016/j.jacc.2012.12.048 · External reference
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
10.1038/s41598-018-32210-x · 2018 · External reference
Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study
10.1371/journal.pone.0094834 · 2014 · External reference
Fatty acid binding protein 3 activates endothelial adhesion of circulating monocytes and impairs endothelial angiogenesis
10.1111/bph.17451 · 2025 · External reference
The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases
10.3390/biomedicines10092283 · 2022 · External reference
10.1186/1475-2840-10-37
10.1186/1475-2840-10-37 · External reference
10.1074/jbc.m314263200
10.1074/jbc.m314263200 · External reference
10.1016/j.bbadis.2008.07.003
10.1016/j.bbadis.2008.07.003 · External reference
Asymmetric dimethylarginine and heart-type fatty acid-binding protein 3 are risk markers of cardiotoxicity in carbon monoxide poisoning cases in Zagazig university hospitals
10.1177/0960327116646621 · 2017 · External reference
Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
10.1016/j.eclinm.2021.100997 · 2021 · External reference
A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals
10.1186/s12944-015-0049-7 · 2015 · External reference
Dose-dependent effects of omega-3 polyunsaturated fatty acids on C-reactive protein concentrations in cardiometabolic disorders: a dose-response meta-analysis of randomized clinical trials
10.1007/s10787-025-01744-8 · 2025 · External reference